Gestodene: Difference between revisions
CSV import |
CSV import |
||
| Line 30: | Line 30: | ||
[[Category:History of medicine]] | [[Category:History of medicine]] | ||
[[Category:Society and culture]] | [[Category:Society and culture]] | ||
<gallery> | |||
Gestodene | |||
File:Gestodene.svg|Chemical structure of Gestodene | |||
File:Gestodeno3D.png|3D model of Gestodene | |||
</gallery> | |||
Revision as of 02:01, 17 February 2025
Gestodene is a progestogen hormonal contraceptive. Products containing gestodene include Meliane, Gynera and Minesse.
Pharmacology
Gestodene is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological target of progestogens like progesterone. It has weak androgenic and glucocorticoid activity and no other important hormonal activity.
Chemistry
Gestodene, also known as 17α-ethynyl-18-methyl-19-nor-δ15-testosterone, is a synthetic estrane steroid and a derivative of testosterone. It is more specifically a derivative of norethisterone (17α-ethynyl-19-nortestosterone) and is a member of the gonane (18-methylestrane) subgroup of the 19-nortestosterone family of progestins.
History
Gestodene was patented in 1975 and introduced for medical use, specifically in birth control pills, in 1987. It was introduced in the United States under the brand name Femodene in 1992.
Society and culture
Gestodene is marketed widely throughout the world. It is available as a combined birth control pill in combination with the estrogen ethinylestradiol under a multitude of brand names.
See also
References
<references />


